This was further corroborated by Ciconte et al., where proven LP/P SCN5A variant carriers had a higher prevalence of aborted cardiac arrest or spontaneous ventricular tachycardia/fibrillation requiring ICD therapy [24]. This evidence concerns the gene SCN5A and cardiac arrest.